The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Innovative platforms for development of TCR-T cell therapies against novel tumor targets: Triple negative breast cancer.
 
Rachel Judith Mary Abbott
Employment - Adaptimmune; Enara Bio; Pan Cancer T
Leadership - Pan Cancer T
Stock and Other Ownership Interests - Adaptimmune; Enara Bio; Pan Cancer T
 
Dora Hammerl
Employment - Pan Cancer T
Stock and Other Ownership Interests - Pan Cancer T
Honoraria - Pan Cancer T
Research Funding - Pan Cancer T
Patents, Royalties, Other Intellectual Property - P128827EP00, P130556EP00
 
Dian Kortleve
Research Funding - Pan Cancer T
 
Mandy van Brakel
Research Funding - Pan Cancer T
 
Rebecca Wijers
Research Funding - Pan Cancer T
 
Daphne Roelofs
Research Funding - Pan Cancer T
 
Madelon Badoux
Research Funding - Pan Cancer T
 
Reno Debets
Employment - Pan Cancer T
Stock and Other Ownership Interests - Pan Cancer T
Consulting or Advisory Role - Bluebird Bio; Genticel; Sanofi
Research Funding - Bayer; MSD
Patents, Royalties, Other Intellectual Property - European patent application no’s. 21152822.9 and 21184727.2 (pending to Erasmus MC)